Back to Results
First PageMeta Content
Nootropics / Medicine / Glimepiride / Sulfonylureas / Galantamine / Medical prescription / Chemistry / Organic chemistry / Janssen Pharmaceutica


IMPORTANT DRUG WARNING October 19, 2004 IMPORTANT SAFETY ALERT REGARDING MEDICATION ERRORS Dear Pharmacist: Janssen Pharmaceutica Products, L.P. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. have re
Add to Reading List

Open Document

File Size: 69,11 KB

Share Result on Facebook

City

TITUSVILLE / /

Company

Janssen Pharmaceutica Products L.P. / Aventis Pharmaceuticals Inc. / Johnson & Johnson Pharmaceutical Research & Development L.L.C. / CNS Janssen Medical Affairs LLC / Johnson & Johnson / /

Event

FDA Phase / /

MedicalCondition

diabetes mellitus / dementia / severe hypoglycemia / /

MedicalTreatment

medication errors / /

Organization

FDA / Institute for Safe Medication Practices / POST OFFICE / /

Person

Ramy Mahmoud / /

/

Position

MPH Vice-President / pharmacist / written and oral prescriptions Counsel / IMPORTANT SAFETY ALERT REGARDING MEDICATION ERRORS Dear Pharmacist / /

Product

REMINYL tablets / Safe Medication / USP Medication / AMARYL / galantamine hydrobromide / IMPORTANT SAFETY ALERT REGARDING MEDICATION / glimepiride / REMINYL® / /

ProvinceOrState

New Jersey / /

SocialTag